FBT
ABBV icon

Founders Bank & Trust’s AbbVie ABBV Stock Holding History

Founders Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$706K Sell
10,784
-205
-2% -$12.9K 0.37% 44
2014
Q3 		$635K Hold
10,989
– – 0.36% 48
2014
Q2 		$621K Hold
10,989
– – 0.34% 50
2014
Q1 		$565K Sell
10,989
-296
-3% -$15K 0.33% 50
2013
Q4 		$538K Sell
11,285
-794
-7% -$39K 0.31% 49
2013
Q3 		$540K Sell
12,079
-439
-4% -$19.5K 0.28% 46
2013
Q2 		$517K Buy
+12,518
New +$547K 0.28% 48

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Founders Bank & Trust's ABBV Position: Q4 2014 in Review

Founders Bank & Trust reduced its AbbVie (ABBV) stake by 1.9% in Q4 2014, selling an estimated $12.9K and leaving 10,784 shares worth $706K. The position accounts for 0.37% of the portfolio, ranked #44.

Founders Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 7 quarters since. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Founders Bank & Trust held 10,784 shares of AbbVie worth $706K as of Q4 2014.
  • Founders Bank & Trust sold 205 AbbVie shares in Q4 2014, an estimated $12.9K.
  • AbbVie made up 0.37% of Founders Bank & Trust's portfolio in Q4 2014, its #44 holding.
  • Founders Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 7 quarters since.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Founders Bank & Trust's 13F filing for Q4 2014, filed 9 Feb 2015.